
6.37BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US76243J1051
CUSIP
76243J105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.50
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.12
Wall Street Target Price
140.53
EPS Estimate Current Year
-3.04
EPS Estimate Next Year
-0.63
EPS Estimate Current Quarter
-0.8329
EPS Estimate Next Quarter
-0.8196
Most Recent Quarter
-
Revenue TTM
239,918,000
Gross Profit TTM
213,528,992
EBITDA
-199,550,000
Profit Margin
-85.59%
Return On Assets TTM
-30.96%
Return On Equity TTM
-117.05%
Revenue Per Share TTM
3.557
Qtly Revenue Growth YOY
46.90%
Diluted Eps TTM
-3.12
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
333
Price Sales TTM
26.5659
Price Book MRQ
61.9169
Enterprise Value Revenue
25
Enterprise Value EBITDA
-12
903.08
3.20%227.40
2.97%965.00
0.55%314.92
0.35%900.30
0.00%139.16
0.00%528.21
-4.77%355.10
-2.26%34.64
-2.01%153.70
-1.47%